Skip to main content

Kura Oncology

La Jolla, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

$150.0M raised
Jan 2024
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kura Oncology

How much funding has Kura Oncology raised?
Kura Oncology has raised $150.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.
Who are Kura Oncology's investors?
Kura Oncology's investors include ARCH Venture Partners, Hercules Capital, Fidelity, Bristol-Myers Squibb, OUP (Osage University Partners).
Where is Kura Oncology headquartered?
Kura Oncology is headquartered in La Jolla, United States.
What does Kura Oncology do?
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
What stage is Kura Oncology at?
Kura Oncology is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kura Oncology — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/kura-oncology. Accessed July 2, 2026.
APA
VCBacked. (2024). Kura Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kura-oncology
Wikipedia (cite web)
{{cite web |title=Kura Oncology — Funding & Investors |url=https://www.vcbacked.co/company/kura-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .